Visma delays IPO plans to 2027 amid market uncertainty By Investing.com

Visma AS has postponed its IPO to next year after previously pushing an early-2026 listing to October and is now unlikely to list this year. The Hg-backed software group's delay—triggered by a tech selloff tied to AI concerns—removes what was expected to be one of Europe's largest IPOs and weakens prospects for a London IPO market comeback; Visma may instead allow a secondary shareholder sell-down. Implication: continued weak appetite for large tech offerings and increased caution around European equity issuance and IPO pipelines.

Analysis

A large, high-quality software IPO postponement is not just a calendar change — it reshuffles exit mechanics for PE-backed tech and shifts where marginal dollars land. With a meaningful tranche of high-multiple supply removed from the public market for months, allocators with near-term liquidity targets will either rotate into liquid AI/compute leaders or sit out, increasing bid concentration in a smaller set of names and widening dispersion between winners and losers over the next 3–9 months.

Second-order winners are liquid hardware/software providers that plug into the AI stack: they become the default public proxies for private software upside and for allocators chasing growth. Conversely, demand-exposed, adtech and mobile-monetization names are more vulnerable to risk-off flows because they lack the clear secular AI demand that supports higher multiple re-rates. Expect an elevated chance of secondary share offerings from sponsors as a path to liquidity — those create episodic supply shocks that can erase short-term moves even while the broader issuance drought supports multiple expansion.

Key catalysts to watch: (1) any visible stabilization in AI investor sentiment (earnings beats from large-cap AI beneficiaries within 2–6 weeks) that could restart issuance, (2) announcements of sponsor secondary blocks which can depress comps for 1–4 weeks around print, and (3) M&A outcomes where strategics buy-to-build — a flurry of trade sales would materially compress expected IPO cadence over 6–12 months. The consensus that the IPO window is permanently closed is overstated; delays concentrate near-term flow and create asymmetric opportunities for liquid AI exposure, but they also raise the probability of episodic supply shocks from secondaries.

Key Decisions for Investors

• Long SMCI (buy shares) — tactical 6–9 month trade: target +30%, stop -15%. Rationale: liquid, direct AI compute proxy that should capture reallocation flows from delayed software IPOs; take profits into strength around catalyst windows (large-cap AI earnings). Position size 2–4% of risk budget.
• Long SMCI call spread (6–9 month calls, debit spread) — defined-risk alternative: buy 1x 9-month call / sell a higher strike call to fund premium. Aim 2:1 reward:risk if SMCI advances on concentrated flow into AI hardware; max loss = premium paid, target ~+40–60% on premium.
• Pair trade — long SMCI / short APP (equal notional) for 3–9 months: target pair performance +20% (SMCI outperformance), stop pair drawdown -10%. Rationale: reallocation into AI compute vs secularly cyclical adtech; hedges market beta while isolating dispersion between AI-capex beneficiaries and ad-revenue cyclicals.